CLDN4 and invasive carcinoma: For example, Abd-Elazeem M.A. and Abd-Elazeem M.A.26 reported high levels of claudin 4 expression in 66.1% of triple-negative breast cancer, particularly in invasive carcinoma, which correlated with the expression of Ki67.